Biosimilars for psoriasis: clinical studies to determine similarity
Biosimilars are drugs that are similar, but not identical, to originator biologics. Pre-clinical analytical studies are required to show similarity on a molecular and structural level, but efficacy and safety studies in humans are essential to ultimately determine biosimilarity. In this review writt...
Збережено в:
Автори: | , , , , , , , , , , , , |
---|---|
Формат: | Revisão |
Мова: | Англійська |
Опубліковано: |
2016
|
Онлайн доступ: | https://doi.org/10.1111/bjd.15067 |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|